Seattle-based biotech startup Sana raises $821 million

“I think the most important thing in building a company and the thing that we want inside Sana is finding a mission that will change outcomes for a broad part of society. And then, create an environment where people feel connected to that mission and can thrive.” Steve Harr, CEO of Seattle-based Sana Biotechnology, discussing Sana’s recent funding round. He said, “At the end of the day, it really does come down to the quality of people that work here. And we have to make sure they can be their best selves.”

Photo: Courtesy Sana Biotechnology

READ THE STORY at The Seattle Times »